McAllen Kids Marathon Kickoff set for Sept. 28

Translate to Spanish or other 102 languages!

Mega Doctor News

- Advertisement -

Now in its sixth year, thousands of kids have benefitted from the McAllen Kids Marathon.

In fact, the annual McAllen Kids Marathon Kickoff will be at 8 a.m. on Saturday, September 28. The event will be at DQ Fan Field at McAllen Veterans Memorial Stadium.

The event is for children in pre-kinder through eighth grade. The students will run their first mile at the Sept. 28 event. Students will continue running during the fall and run the final mile of their 26.2-mile marathon in January at the McAllen Convention Center.

- Advertisement -

“Exercise is vital for children’s upbringing,” Event Organizer and McAllen ISD PE and Health Coordinator Mario Reyna said. “By instilling healthy habits in children at a young age, those habits can then benefit children for their entire lives. This is a great event for children and families.”

Representatives from McAllen ISD and the City of McAllen are co-organizing the event with support from the community. There will be music, mascots, cheerleaders and more.

Kids can register for free with their PE coach or online at mcallenkidsmarathon.com.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health Raises Over $520K at 20th “Fishing for Hope” Event

DHR Health made a big splash at the 20th Annual “Fishing for Hope” Tournament, held on August 22 at Jim’s Pier in South Padre Island, raising an impressive grand total of $524,130.

FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer

The U.S. Food and Drug Administration approved Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic cancer—delivering a new treatment option to patients with advanced pancreatic cancer months ahead of schedule. 

Moderna and Merck Report Positive Phase 3 Results for Personalized Cancer Therapy

Moderna and Merck have reached a major clinical milestone after their investigational individualized cancer therapy, combined with Merck’s Keytruda, produced positive results in a Phase 3 study involving patients with high-risk melanoma.

STHS Scores Fourth Consecutive 5-Star Rating for Diabetic Care

Diabetes remains one of the nation’s most pressing health challenges, with a disease once largely associated with older adults now affecting younger populations at an alarming rate.
- Advertisement -